Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
about
What research is needed to stop TB? Introducing the TB Research MovementXpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistanceEffect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysisTuberculosis vaccines and prevention of infectionThe use of supplementary immunisation activities to improve uptake of current and future vaccines in low-income and middle-income countries: a systematic review protocolData needs for evidence-based decisions: a tuberculosis modeler's 'wish list'MR1-restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosisSlow elimination of multidrug-resistant tuberculosisThe population dynamics and control of tuberculosisThe ongoing challenge of latent tuberculosisThe Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical ModellingNovel vaccination strategies against tuberculosis.Concise gene signature for point-of-care classification of tuberculosisAfter 2015: infectious diseases in a new era of health and development.Respiratory health issues in the Asia-Pacific region: an overview.A review of the literature on the economics of vaccination against TB.PCR to detect Mycobacterium tuberculosis in respiratory tract samples: evaluation of clinical data.Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis.Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901.Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study.SLC11A1 (NRAMP1) polymorphisms and tuberculosis susceptibility: updated systematic review and meta-analysis.In vitro immunomodulation for enhancing T cell-based diagnosis of Mycobacterium tuberculosis infection.A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis.Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults.Evaluation of tuberculosis diagnostics: establishing an evidence base around the public health impact.Impact of blood volume, tube shaking, and incubation time on reproducibility of QuantiFERON-TB gold in-tube assay.Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.Modeling of novel diagnostic strategies for active tuberculosis - a systematic review: current practices and recommendations.Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countriesPredicting U.S. tuberculosis case counts through 2020.Population-level impact of same-day microscopy and Xpert MTB/RIF for tuberculosis diagnosis in Africa.Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementationContact tracing of tuberculosis: a systematic review of transmission modelling studies.Identification of human T-cell responses to Mycobacterium tuberculosis resuscitation-promoting factors in long-term latently infected individuals.ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccination.Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysisModeling the impact of tuberculosis interventions on epidemiologic outcomes and health system costs.Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry.Pregnancy differentially impacts performance of latent tuberculosis diagnostics in a high-burden setting.
P2860
Q21563033-367838AE-711F-488D-A7E3-ED75083C8F16Q22241307-DEDEC3C0-78F2-40C3-8ECB-43F8E65B83B6Q22242062-4A13B165-AC97-43A4-9E86-78E0CC3DA32AQ26782022-28542F5B-9845-4DD8-BA09-F917504152ABQ26864948-C796BFCE-AA7A-4994-BD1A-A9D6D44603A3Q27015848-F1629C6F-ED2F-458C-9914-7419C6F5C41BQ27016137-85F7B712-05FD-4CD1-9B91-F2839AAF109FQ28278696-676631E2-1C5A-440A-946E-E58063C9D51DQ28282446-297757E6-33B2-45FF-8860-4B3E45D7135BQ28386135-445AA71A-6BD1-4FC4-9A1B-93AA5627A556Q30244104-C3F8CBDD-B019-41DB-AA5C-C2604A1A8FC3Q30363188-3B012B9D-DC9B-48E1-948C-5672C0C7D354Q30382646-499FC662-422F-4F05-9F0B-91A086A4C0CAQ30391463-87370786-B0F7-47D3-96A2-6F2E07223A7BQ30394490-4D99BCC1-BA8F-480B-8A13-28B0408FD02EQ30413692-E6424021-B0E7-48F4-A7E0-5BB8F8577841Q30672984-EB0A4686-0497-49ED-987A-331F8D2A006AQ30830344-EA3726A6-2873-4FA7-9A34-8B4A1E9B16FBQ33675370-400FD995-FB80-47E3-88D9-B378118C55B5Q33735589-FCA58E36-DF54-4470-8B16-1263F89212B4Q33804506-EC1F9F18-B479-4B06-9190-5245A135C380Q33808658-804E00C1-B477-4DB8-BA11-A29632954AE5Q33824247-996EDA38-F3F8-424C-820C-A489AA7A8052Q33847279-AB0F2188-A94E-44A8-9BFC-15FBA7834CB1Q34055234-5B562F94-329D-499F-875C-AAFD5D8AE955Q34224000-0EB2DB18-A53D-4559-BCDE-40A093305124Q34365728-9A613B28-D66F-4BB9-8FCF-0545D60EE158Q34387168-1878D0FD-7511-4C29-B7C4-0A8642AC9CDFQ34395434-EBB46891-07BA-43D7-A1AC-23349F53C90FQ34441930-91CF3323-D407-4E7A-9946-FBEF760D20C4Q34778665-F287FB99-378E-442F-AAF0-EB49835FBE98Q34947034-97F8871E-6767-40BF-B601-BD12EB81D70AQ34976354-574ABFA5-16BF-42A6-BC5E-0E7790362E5FQ34983930-21BF5509-47A8-45BE-88E7-014E2F214113Q35066262-02F8DD82-88DA-45C8-8498-84DF7AF7F581Q35069386-7306DC98-A0A4-455F-A031-985C0769D9E9Q35075418-DB6CA737-313C-4B3B-AE94-B93D532C2CB0Q35105344-FFF5E7B4-337D-4C74-9D69-782AF5FF34A7Q35117812-55679DA7-7EB3-44FA-83DB-D7B40AC3D45CQ35127992-F1784456-B327-4CD4-84C8-888C9B88B451
P2860
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
@en
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics.
@nl
type
label
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
@en
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics.
@nl
prefLabel
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
@en
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics.
@nl
P2860
P50
P921
P356
P1476
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
@en
P2093
Jerusha T Achterberg
Lorenzo Sabatelli
P2860
P304
13980-13985
P356
10.1073/PNAS.0901720106
P407
P577
2009-08-03T00:00:00Z